nProfiler I Stomach Cancer Assay Kit
nProfiler I Stomach Cancer Assay Kit is a medical device with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
No phase data available
Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Status
Recent Activity
Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer
A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test
Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer
A Validation Study of Relationships Among Genomic Gene Expression Profile, Prognosis and Prediction of Adjuvant Chemotherapy Benefit With Capecitabine and Oxaliplatin in Gastric Cancer Stage II and III (6th AJCC) Patients After D2 Surgery (CLASSIC)
Clinical Trials (4)
Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer
A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test
Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer
A Validation Study of Relationships Among Genomic Gene Expression Profile, Prognosis and Prediction of Adjuvant Chemotherapy Benefit With Capecitabine and Oxaliplatin in Gastric Cancer Stage II and III (6th AJCC) Patients After D2 Surgery (CLASSIC)
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4